Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Sorry EV Stocks to Sell in May Before It’s Too Late

By Josh Enomoto, InvestorPlace Contributor

While the electrification of mobility may be a done deal, that doesn’t mean everyone will win as these EV stocks to sell confirm.

Stocks to Buy: 7 Earnings Winners to Load Up on in May

By Josh Enomoto, InvestorPlace Contributor

With so much going on in the economy, investors may feel more confidence betting on established earnings winners stocks.

7 Generative AI Stocks to Buy as the Machines Take Over

By Josh Enomoto, InvestorPlace Contributor

With digital innovations integrating into all areas of our lives, investors should target the best generative AI stocks to buy.

The 7 Most Promising Water Industry Stocks to Buy in 2023

By Josh Enomoto, InvestorPlace Contributor

With a brewing water crisis and the precious commodity incurring demand spikes, these water stocks just might fly higher.

7 Virtual Reality Stocks to Buy for Immersive Gains

By Josh Enomoto, InvestorPlace Contributor

With immersion technologies expanding in scope and scale, these virtual reality stocks to buy should be on your radar.

7 Infrastructure Stocks With Huge Return Potential for Long-Term Investors

By Josh Enomoto, InvestorPlace Contributor

While the concept of infrastructure stocks to buy is boring as heck, the underlying predictability may intrigue investors.

Why Is Bluebird Bio (BLUE) Stock Up 17% Today?

By Josh Enomoto, InvestorPlace Contributor

Bluebird Bio received a major lift from JPMorgan Chase regarding its gene-editing therapeutic, sending BLUE stock flying.

7 Nasdaq Small-Cap Stocks Set to Outperform in 2023

By Josh Enomoto, InvestorPlace Contributor

While wagering on speculative ventures presents high risks, these Nasdaq small-cap stocks should be on your watch list.

7 Stocks That Will Get Pummeled When the Real Estate Bubble Pops

By Josh Enomoto, InvestorPlace Contributor

While the housing market and its players had a good run, investors may now want to avoid real estate bubble stocks.

7 Small-Cap Biotech Stocks with Massive Potential

By Josh Enomoto, InvestorPlace Contributor

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

Load More